Arcutis Biotherapeutics Inc Corporate Analyst Meeting Transcript
Welcome to those of you in the room, really appreciate you guys coming and joining us here in Boston. And for those of you online, thank you for joining us as well. I'm Frank Watanabe, I'm the President and CEO of Arcutis Biotherapeutics, and I'm joined today by Patrick Burnett, who is our Chief Medical Officer; and Ken Lock, who is our Chief Commercial Officer. And a little bit later when we get to the Q&A session, I'm going to be -- we'll be joined by Scott Burrows, our Chief Financial Officer as well.
So we are going to be discussing some forward-looking statements. So when you get a chance, if you would, please review the legal disclaimers. I know you can't read them now.
So just a quick overview of what to expect for today. Especially, for those of who are a little less familiar with the Arcutis story, I'll start out with an overview of the company, an overall overview. And then Patrick and Ken are going to drill in more on psoriasis. Patrick will give you an update on the clinical data on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
